Polycystic Ovary Syndrome News

Women with polycystic ovary syndrome have less increase in follicle-stimulating hormone after triptorelin administration during in vitro fertilization than women without PCOS, according to data from two studies.

Increased phthalate metabolite concentrations may contribute to obesity, glucose impairment and dislipidemia among women with polycystic ovary syndrome, according to study findings published in Clinica Chimica Acta.

Magnesium supplementation for 10 weeks led to no beneficial effects for women with polycystic ovary syndrome experiencing hyperandrogenism, hirsutism and impaired sleep quality, researchers reported in Health Science Reports.

Irregular and long menstrual cycles were associated with elevated risk for incident CVD events, primarily CHD, according to research published in JAMA Network Open.

ANAHEIM, Calif. — Instagram users are engaging content about polycystic ovarian syndrome from accounts dedicated to the topic, and patients can be encouraged to find support there, according to findings presented here.

ANAHEIM, Calif. — Women with polycystic ovary syndrome may be more likely to have cognitive decline and reductions in white brain matter integrity than those without PCOS, according to a presenter.

ANAHEIM, Calif. — Women with polycystic ovary syndrome are more likely to develop type 2 diabetes and may develop hypertension, diabetes and hyperlipidemia earlier than those without PCOS, according to a speaker.

Regional differences in hormonal and metabolic profiles in polycystic ovary syndrome exist between women in Alabama, who are more likely to have hirsutism, and those California, who are more likely to have hyperandrogenemia.

Each year, the CDC recognizes National Women’s Health & Fitness Day to highlight the importance of exercise for all women. This year, the day of recognition falls on Sept. 28.

September is designated Polycystic Ovary Syndrome Awareness Month to raise awareness of the reproductive condition.